Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of european randomized clinical trials

Journal of Clinical Oncology

Volumn 29, Issue 23, 2011, Pages 3163-3172

  Valentini, Vincenzo ^a   Van Stiphout, Ruud G P M ^c,d   Lammering, Guido ^c   Gambacorta, Maria Antonietta ^a   Barba, Maria Cristina ^a   Bebenek, Marek ^e   Bonnetain, Franck ^g   Bosset, Jean Francois ^h   Bujko, Krzysztof ^f   Cionini, Luca ^b   Gerard, Jean Pierre ⁱ   Rödel, Claus ^j   Sainato, Aldo ^b   Sauer, Rolf ^k   Minsky, Bruce D ^l   Collette, Laurence ^m   Lambin, Philippe ^c  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e Silesian Oncological Centre   (Poland)

^f INSTITUTE OF ONCOLOGY   (Poland)

^g UNIVERSITÉ DE BOURGOGNE   (France)

^h UNIVERSITY HOSPITAL OF BESANÇON   (France)

ⁱ CENTRE ANTOINE LACASSAGNE   (France)

^j GOETHE UNIVERSITY   (Germany)

^k UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^l UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^m EORTC DATA CENTER   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ACCURACY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CHEMORADIOTHERAPY; DISTANT METASTASIS; EUROPE; FEMALE; HIGH RISK POPULATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OVERALL SURVIVAL; PATIENT SELECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CANCER; TREATMENT OUTCOME; VALIDATION PROCESS;

ADULT; AGE FACTORS; AGED; EUROPE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS; SEX FACTORS;

EID: 80051808651     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.33.1595     Document Type: Article

References (39)

1. Bosset J.F., Collette L., Calais G., et al: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123, 2006 (Pubitemid 44394918)
2. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al: Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215-1223, 2006 (Pubitemid 44547018)
3. Gérard J.P., Conroy T., Bonnetain F., et al: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 24:4620-4625, 2006 (Pubitemid 46630960)
4. Peeters K.C., Marijnen C.A., Nagtegaal I.D., et al: The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693-701, 2007 (Pubitemid 350035641)
5. Sebag-Montefiore D., Stephens R.J., Steele R., et al: Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet 373:811-820, 2009
6. Quasar Collaborative Group, Gray R, Barnwell J, et al: Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomised study. Lancet 370:2020-2029, 2007
7. Valentini V., Aristei C., Glimelius B., et al: Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 92:148-163, 2009
8. Jeffery G.M., Hickey B.E., Hider P.: Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 1:CD002200, 2002
9. Rosen M., Chan L., Beart R.W. Jr, et al: Follow-up of colorectal cancer: A meta-analysis. Dis Colon Rectum 41:1116-1126, 1998 (Pubitemid 28432452)
10. Weiser M.R., Landmann R.G., Kattan M.W., et al: Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol 26:380-385, 2008 (Pubitemid 351171688)
11. Kattan M.W., Gönen M., Jarnagin W.R., et al: A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg 247:282-287, 2008 (Pubitemid 351156771)
12. Massacesi C., Norman A., Price T., et al: A clinical nomogram for predicting long-term survival in advanced colorectal cancer. Eur J Cancer 36:2044-2052, 2000
13. Sauer R., Becker H., Hohenberger W., et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740, 2004
14. Bujko K., Nowacki M.P., Kepka L., et al: Postoperative complications in patients irradiated preoperatively for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs chemoradiation. Colorectal Dis 7:410-416, 2005 (Pubitemid 40894874)
15. Reference deleted.
16. Schafer J.L.: Analysis Of Incomplete Multivariate Data: Monographs on Statistics and Applied Probability 72. London, United Kingdom, Chapman & Hall/CRC, 1997
17. Kaplan E.L., Meier P.: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
18. Steyerberg E.W.: Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating (Statistics for Biology and Health). New York, New York, Springer, 2009
19. Harrell F.E. Jr: Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis (Springer Series in Statistics). New York, New York, Springer, 2001
20. Iasonos A., Schrag D., Raj G.V., et al: How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26:1364-1370, 2008
21. Maas M., Nelemans P.J., Valentini V., et al: Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data. Lancet Oncol 11:835-844, 2010
22. Capirci C., Valentini V., Cionini L., et al: Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 72:99-107, 2008
23. Vecchio F.M., Valentini V., Minsky B.D., et al: The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 62:752-760, 2005 (Pubitemid 40779765)
24. Quirke P., Steele R., Monson J., et al: Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: A prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373:821-828, 2009
25. Holm T., Ljung A., Häggmark T., et al: Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 94:232-238, 2007 (Pubitemid 46340406)
26. Marr R., Birbeck K., Garvican J., et al: The modern abdominoperineal excision: The next challenge after total mesorectal excision. Ann Surg 242:74-82, 2005 (Pubitemid 40917970)
27. West N.P., Finan P.J., Anderin C., et al: Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol 26:3517-3522, 2008
28. Janjan N.A., Crane C.N., Feig B.W., et al: Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 47:713-718, 2000 (Pubitemid 30317490)
29. Mohiuddin M., Winter K., Mitchell E., et al: Randomized phase II study of neoadjuvant combinedmodality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 24:650-655, 2006 (Pubitemid 46630429)
30. Myerson R.J., Valentini V., Birnbaum E.H., et al: A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma. Int J Radiat Oncol Biol Phys 50:1299-1308, 2001 (Pubitemid 32727809)
31. Valentini V., Morganti A.G., Luzi S., et al: Is chemoradiation feasible in elderly patients? A study of 17 patients with anorectal carcinoma. Cancer 80:1387-1392, 1997 (Pubitemid 27441011)
32. Rutten H.J., Den Dulk M., Lemmens V.E., et al: Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol 9:494-501, 2008 (Pubitemid 351626863)
33. Tepper J.E., Wang A.Z.: Improving local control in rectal cancer: Radiation sensitizers or radiation dose? J Clin Oncol 28:1623-1624, 2010
34. Fisher B., Wolmark N., Rockette H., et al: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01. J Natl Cancer Inst 80:21-29, 1988 (Pubitemid 18076565)
35. Aschele C., Pinto C., Cordio S., et al: Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial. J Clin Oncol 27:170s, 2009 (suppl: abstr CRA4008)
36. Gérard J.P., Azria D., Gourgou-Bourgade S., et al: Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 28:1638-1644, 2010
37. Kusters M., Valentini V., Calvo F.A., et al: Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: Adjuvant chemotherapy prevents local recurrence rather than distant metastases. Ann Oncol 21:1279-1284, 2009
38. Dekker J.W., Peeters K.C., Putter H., et al: Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification. Eur J Surg Oncol 36:1180-1186, 2010
39. Nissan A., Stojadinovic A., Shia J., et al: Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol 24:4078-4084, 2006 (Pubitemid 46622282)